Batch_ID,Level1,Level2,Samples,Samples_ID,Replicates_ID,Replicates,Concentrations_ID,Date,Run date,Concentrations
exp010821,Controls,Control,Control,Contro,Contro1_000u_exp010821_run180821_03,4,000u,2021-08-01,2021-08-18,0
exp010821,Controls,Control,Control,Contro,Contro2_000u_exp010821_run180821_04,4,000u,2021-08-01,2021-08-18,0
exp010821,Controls,Control,Control,Contro,Contro3_000u_exp010821_run180821_05,4,000u,2021-08-01,2021-08-18,0
exp010821,Controls,Control,Control,Contro,Contro4_000u_exp010821_run180821_06,4,000u,2021-08-01,2021-08-18,0
exp040821,Controls,Control,Control,Contro,Contro1_000u_exp040821_run180821_25,4,000u,2021-08-04,2021-08-18,0
exp040821,Controls,Control,Control,Contro,Contro2_000u_exp040821_run180821_26,4,000u,2021-08-04,2021-08-18,0
exp040821,Controls,Control,Control,Contro,Contro3_000u_exp040821_run180821_27,4,000u,2021-08-04,2021-08-18,0
exp040821,Controls,Control,Control,Contro,Contro4_000u_exp040821_run180821_28,4,000u,2021-08-04,2021-08-18,0
exp300821,Controls,Control,Control,Contro,Contro1_000u_exp300821_run290921_01,4,000u,2021-08-30,2021-09-29,0
exp300821,Controls,Control,Control,Contro,Contro2_000u_exp300821_run290921_02,4,000u,2021-08-30,2021-09-29,0
exp300821,Controls,Control,Control,Contro,Contro3_000u_exp300821_run290921_03,4,000u,2021-08-30,2021-09-29,0
exp300821,Controls,Control,Control,Contro,Contro4_000u_exp300821_run290921_04,4,000u,2021-08-30,2021-09-29,0
exp130921,Controls,Control,Control,Contro,Contro1_000u_exp130921_run290921_32,4,000u,2021-09-13,2021-09-29,0
exp130921,Controls,Control,Control,Contro,Contro2_000u_exp130921_run290921_33,4,000u,2021-09-13,2021-09-29,0
exp130921,Controls,Control,Control,Contro,Contro3_000u_exp130921_run290921_34,4,000u,2021-09-13,2021-09-29,0
exp130921,Controls,Control,Control,Contro,Contro4_000u_exp130921_run290921_35,4,000u,2021-09-13,2021-09-29,0
exp200921,Controls,Control,Control,Contro,Contro1_000u_exp200921_run111021_09,4,000u,2021-09-20,2021-10-11,0
exp200921,Controls,Control,Control,Contro,Contro2_000u_exp200921_run111021_10,4,000u,2021-09-20,2021-10-11,0
exp200921,Controls,Control,Control,Contro,Contro3_000u_exp200921_run111021_11,4,000u,2021-09-20,2021-10-11,0
exp200921,Controls,Control,Control,Contro,Contro4_000u_exp200921_run111021_12,4,000u,2021-09-20,2021-10-11,0
exp181021,Controls,Control,Control,Contro,Contro1_000u_exp181021_run101121_38,4,000u,2021-10-18,2021-11-10,0
exp181021,Controls,Control,Control,Contro,Contro2_000u_exp181021_run101121_39,4,000u,2021-10-18,2021-11-10,0
exp181021,Controls,Control,Control,Contro,Contro3_000u_exp181021_run101121_40,4,000u,2021-10-18,2021-11-10,0
exp181021,Controls,Control,Control,Contro,Contro4_000u_exp181021_run101121_41,4,000u,2021-10-18,2021-11-10,0
exp151121,Controls,Control,Control,Contro,Contro1_000u_exp151121_run071221_01,4,000u,2021-11-15,2021-12-07,0
exp151121,Controls,Control,Control,Contro,Contro2_000u_exp151121_run071221_02,4,000u,2021-11-15,2021-12-07,0
exp151121,Controls,Control,Control,Contro,Contro3_000u_exp151121_run071221_03,4,000u,2021-11-15,2021-12-07,0
exp151121,Controls,Control,Control,Contro,Contro4_000u_exp151121_run071221_04,4,000u,2021-11-15,2021-12-07,0
exp271221,Controls,Control,Control,Contro,Contro1_000u_exp271221_run180122_17,4,000u,2021-12-27,2022-01-18,0
exp271221,Controls,Control,Control,Contro,Contro2_000u_exp271221_run180122_18,4,000u,2021-12-27,2022-01-18,0
exp271221,Controls,Control,Control,Contro,Contro3_000u_exp271221_run180122_19,4,000u,2021-12-27,2022-01-18,0
exp271221,Controls,Control,Control,Contro,Contro4_000u_exp271221_run180122_20,4,000u,2021-12-27,2022-01-18,0
exp070222,Controls,Control,Control,Contro,Contro1_000u_exp070222_run010322_01,4,000u,2022-02-07,2022-03-01,0
exp070222,Controls,Control,Control,Contro,Contro2_000u_exp070222_run010322_02,4,000u,2022-02-07,2022-03-01,0
exp070222,Controls,Control,Control,Contro,Contro3_000u_exp070222_run010322_03,4,000u,2022-02-07,2022-03-01,0
exp070222,Controls,Control,Control,Contro,Contro4_000u_exp070222_run010322_04,4,000u,2022-02-07,2022-03-01,0
exp220322,Controls,Control,Control,Contro,Contro1_000u_exp220322_run060522_25,4,000u,2022-03-22,2022-05-06,0
exp220322,Controls,Control,Control,Contro,Contro2_000u_exp220322_run060522_26,4,000u,2022-03-22,2022-05-06,0
exp220322,Controls,Control,Control,Contro,Contro3_000u_exp220322_run060522_27,4,000u,2022-03-22,2022-05-06,0
exp220322,Controls,Control,Control,Contro,Contro4_000u_exp220322_run060522_28,4,000u,2022-03-22,2022-05-06,0
exp130921,Controls,Control,Control,Contro,Contro1_000u_exp130921_run101121_20,8,000u,2021-09-13,2021-11-10,0
exp130921,Controls,Control,Control,Contro,Contro2_000u_exp130921_run101121_21,8,000u,2021-09-13,2021-11-10,0
exp130921,Controls,Control,Control,Contro,Contro3_000u_exp130921_run101121_22,8,000u,2021-09-13,2021-11-10,0
exp130921,Controls,Control,Control,Contro,Contro4_000u_exp130921_run101121_23,8,000u,2021-09-13,2021-11-10,0
exp130921,Controls,Control,Control,Contro,Contro5_000u_exp130921_run101121_24,8,000u,2021-09-13,2021-11-10,0
exp130921,Controls,Control,Control,Contro,Contro6_000u_exp130921_run101121_25,8,000u,2021-09-13,2021-11-10,0
exp130921,Controls,Control,Control,Contro,Contro7_000u_exp130921_run101121_26,8,000u,2021-09-13,2021-11-10,0
exp130921,Controls,Control,Control,Contro,Contro8_000u_exp130921_run101121_27,8,000u,2021-09-13,2021-11-10,0
exp200921,EGFR,3rd generation EGFR-TKIs,Osimertinb,Osimer,Osimer1_020n_exp200921_run101121_03,4,020n,2021-09-20,2021-11-10,2e-8
exp200921,EGFR,3rd generation EGFR-TKIs,Osimertinb,Osimer,Osimer2_020n_exp200921_run101121_04,4,020n,2021-09-20,2021-11-10,2e-8
exp200921,EGFR,3rd generation EGFR-TKIs,Osimertinb,Osimer,Osimer3_020n_exp200921_run101121_05,4,020n,2021-09-20,2021-11-10,2e-8
exp200921,EGFR,3rd generation EGFR-TKIs,Osimertinb,Osimer,Osimer4_020n_exp200921_run101121_06,4,020n,2021-09-20,2021-11-10,2e-8
exp200921,EGFR,3rd generation EGFR-TKIs,Osimertinb,Osimer,Osimer1_001u_exp200921_run101121_11,4,001u,2021-09-20,2021-11-10,1e-6
exp200921,EGFR,3rd generation EGFR-TKIs,Osimertinb,Osimer,Osimer2_001u_exp200921_run101121_12,4,001u,2021-09-20,2021-11-10,1e-6
exp200921,EGFR,3rd generation EGFR-TKIs,Osimertinb,Osimer,Osimer3_001u_exp200921_run101121_13,4,001u,2021-09-20,2021-11-10,1e-6
exp200921,EGFR,3rd generation EGFR-TKIs,Osimertinb,Osimer,Osimer4_001u_exp200921_run101121_14,4,001u,2021-09-20,2021-11-10,1e-6
exp200921,EGFR,3rd generation EGFR-TKIs,Osimertinb,Osimer,Osimer1_005u_exp200921_run101121_15,4,005u,2021-09-20,2021-11-10,4.9999999999999996e-6
exp200921,EGFR,3rd generation EGFR-TKIs,Osimertinb,Osimer,Osimer2_005u_exp200921_run101121_16,4,005u,2021-09-20,2021-11-10,4.9999999999999996e-6
exp200921,EGFR,3rd generation EGFR-TKIs,Osimertinb,Osimer,Osimer3_005u_exp200921_run101121_17,4,005u,2021-09-20,2021-11-10,4.9999999999999996e-6
exp200921,EGFR,3rd generation EGFR-TKIs,Osimertinb,Osimer,Osimer4_005u_exp200921_run101121_18,4,005u,2021-09-20,2021-11-10,4.9999999999999996e-6
exp271221,EGFR,3rd generation EGFR-TKIs,WZ4002,WZ4002,WZ40021_001u_exp271221_run140122_01,4,001u,2021-12-27,2022-01-14,1e-6
exp271221,EGFR,3rd generation EGFR-TKIs,WZ4002,WZ4002,WZ40022_001u_exp271221_run140122_02,4,001u,2021-12-27,2022-01-14,1e-6
exp271221,EGFR,3rd generation EGFR-TKIs,WZ4002,WZ4002,WZ40023_001u_exp271221_run140122_03,4,001u,2021-12-27,2022-01-14,1e-6
exp271221,EGFR,3rd generation EGFR-TKIs,WZ4002,WZ4002,WZ40024_001u_exp271221_run140122_04,4,001u,2021-12-27,2022-01-14,1e-6
exp070222,EGFR,3rd generation EGFR-TKIs,Lazertinib,Lazert,Lazert1_001u_exp070222_run010322_33,4,001u,2022-02-07,2022-03-01,1e-6
exp070222,EGFR,3rd generation EGFR-TKIs,Lazertinib,Lazert,Lazert2_001u_exp070222_run010322_34,4,001u,2022-02-07,2022-03-01,1e-6
exp070222,EGFR,3rd generation EGFR-TKIs,Lazertinib,Lazert,Lazert3_001u_exp070222_run010322_35,4,001u,2022-02-07,2022-03-01,1e-6
exp070222,EGFR,3rd generation EGFR-TKIs,Lazertinib,Lazert,Lazert4_001u_exp070222_run010322_36,4,001u,2022-02-07,2022-03-01,1e-6
exp070222,EGFR,3rd generation EGFR-TKIs,Rociletinib,Rocile,Rocile1_001u_exp070222_run010322_37,4,001u,2022-02-07,2022-03-01,1e-6
exp070222,EGFR,3rd generation EGFR-TKIs,Rociletinib,Rocile,Rocile2_001u_exp070222_run010322_38,4,001u,2022-02-07,2022-03-01,1e-6
exp070222,EGFR,3rd generation EGFR-TKIs,Rociletinib,Rocile,Rocile3_001u_exp070222_run010322_39,4,001u,2022-02-07,2022-03-01,1e-6
exp070222,EGFR,3rd generation EGFR-TKIs,Rociletinib,Rocile,Rocile4_001u_exp070222_run010322_40,4,001u,2022-02-07,2022-03-01,1e-6
exp070222,EGFR,3rd generation EGFR-TKIs,Mavelertinib,Mavele,Mavele1_001u_exp070222_run010322_41,4,001u,2022-02-07,2022-03-01,1e-6
exp070222,EGFR,3rd generation EGFR-TKIs,Mavelertinib,Mavele,Mavele2_001u_exp070222_run010322_42,4,001u,2022-02-07,2022-03-01,1e-6
exp070222,EGFR,3rd generation EGFR-TKIs,Mavelertinib,Mavele,Mavele3_001u_exp070222_run010322_43,4,001u,2022-02-07,2022-03-01,1e-6
exp070222,EGFR,3rd generation EGFR-TKIs,Mavelertinib,Mavele,Mavele4_001u_exp070222_run010322_44,4,001u,2022-02-07,2022-03-01,1e-6
exp300821,EGFR,1st generation EGFR-TKIs,Gefitinib,Gefiti,Gefiti1_002u_exp300821_run290921_13,4,002u,2021-08-30,2021-09-29,2e-6
exp300821,EGFR,1st generation EGFR-TKIs,Gefitinib,Gefiti,Gefiti2_002u_exp300821_run290921_14,4,002u,2021-08-30,2021-09-29,2e-6
exp300821,EGFR,1st generation EGFR-TKIs,Gefitinib,Gefiti,Gefiti3_002u_exp300821_run290921_15,4,002u,2021-08-30,2021-09-29,2e-6
exp300821,EGFR,1st generation EGFR-TKIs,Gefitinib,Gefiti,Gefiti4_002u_exp300821_run290921_16,4,002u,2021-08-30,2021-09-29,2e-6
exp151121,EGFR,1st generation EGFR-TKIs,Gefitinib,Gefiti,Gefiti1_002u_exp151121_run071221_13,4,002u,2021-11-15,2021-12-07,2e-6
exp151121,EGFR,1st generation EGFR-TKIs,Gefitinib,Gefiti,Gefiti2_002u_exp151121_run071221_14,4,002u,2021-11-15,2021-12-07,2e-6
exp151121,EGFR,1st generation EGFR-TKIs,Gefitinib,Gefiti,Gefiti3_002u_exp151121_run071221_15,4,002u,2021-11-15,2021-12-07,2e-6
exp151121,EGFR,1st generation EGFR-TKIs,Gefitinib,Gefiti,Gefiti4_002u_exp151121_run071221_16,4,002u,2021-11-15,2021-12-07,2e-6
exp151121,EGFR,PROTAC conjugated,Gefitinib-PROTAC-1,PROTAC,PROTAC1_010u_exp151121_run071221_17,4,010u,2021-11-15,2021-12-07,9.999999999999999e-6
exp151121,EGFR,PROTAC conjugated,Gefitinib-PROTAC-1,PROTAC,PROTAC2_010u_exp151121_run071221_18,4,010u,2021-11-15,2021-12-07,9.999999999999999e-6
exp151121,EGFR,PROTAC conjugated,Gefitinib-PROTAC-1,PROTAC,PROTAC3_010u_exp151121_run071221_19,4,010u,2021-11-15,2021-12-07,9.999999999999999e-6
exp151121,EGFR,PROTAC conjugated,Gefitinib-PROTAC-1,PROTAC,PROTAC4_010u_exp151121_run071221_20,4,010u,2021-11-15,2021-12-07,9.999999999999999e-6
exp271221,KRAS,PROTAC conjugated,y-27632 dihydrochloride,Sotora,Sotora1_035u_exp271221_run140122_05,4,035u,2021-12-27,2022-01-14,3.5e-5
exp271221,KRAS,PROTAC conjugated,y-27632 dihydrochloride,Sotora,Sotora2_035u_exp271221_run140122_06,4,035u,2021-12-27,2022-01-14,3.5e-5
exp271221,KRAS,PROTAC conjugated,y-27632 dihydrochloride,Sotora,Sotora3_035u_exp271221_run140122_07,4,035u,2021-12-27,2022-01-14,3.5e-5
exp271221,KRAS,PROTAC conjugated,y-27632 dihydrochloride,Sotora,Sotora4_035u_exp271221_run140122_08,4,035u,2021-12-27,2022-01-14,3.5e-5
exp300821,RAF,PROTAC conjugated,CCT196969,CCT196,CCT1961_001u_exp300821_run290921_25,4,001u,2021-08-30,2021-09-29,1e-6
exp300821,RAF,PROTAC conjugated,CCT196969,CCT196,CCT1962_001u_exp300821_run290921_26,4,001u,2021-08-30,2021-09-29,1e-6
exp300821,RAF,PROTAC conjugated,CCT196969,CCT196,CCT1963_001u_exp300821_run290921_27,4,001u,2021-08-30,2021-09-29,1e-6
exp300821,RAF,PROTAC conjugated,CCT196969,CCT196,CCT1964_001u_exp300821_run290921_28,4,001u,2021-08-30,2021-09-29,1e-6
exp151121,RAF,PROTAC conjugated,CCT196969,CCT196,CCT1961_001u_exp151121_run071221_25,4,001u,2021-11-15,2021-12-07,1e-6
exp151121,RAF,PROTAC conjugated,CCT196969,CCT196,CCT1962_001u_exp151121_run071221_26,4,001u,2021-11-15,2021-12-07,1e-6
exp151121,RAF,PROTAC conjugated,CCT196969,CCT196,CCT1963_001u_exp151121_run071221_27,4,001u,2021-11-15,2021-12-07,1e-6
exp151121,RAF,PROTAC conjugated,CCT196969,CCT196,CCT1964_001u_exp151121_run071221_28,4,001u,2021-11-15,2021-12-07,1e-6
exp130921,RAF,PROTAC conjugated,LY3009120,LY3009,LY30091_003u_exp130921_run290921_36,4,003u,2021-09-13,2021-09-29,3e-6
exp130921,RAF,PROTAC conjugated,LY3009120,LY3009,LY30092_003u_exp130921_run290921_37,4,003u,2021-09-13,2021-09-29,3e-6
exp130921,RAF,PROTAC conjugated,LY3009120,LY3009,LY30093_003u_exp130921_run290921_38,4,003u,2021-09-13,2021-09-29,3e-6
exp130921,RAF,PROTAC conjugated,LY3009120,LY3009,LY30094_003u_exp130921_run290921_39,4,003u,2021-09-13,2021-09-29,3e-6
exp151121,RAF,PROTAC conjugated,LY3009120,LY3009,LY30091_003u_exp151121_run071221_29,4,003u,2021-11-15,2021-12-07,3e-6
exp151121,RAF,PROTAC conjugated,LY3009120,LY3009,LY30092_003u_exp151121_run071221_30,4,003u,2021-11-15,2021-12-07,3e-6
exp151121,RAF,PROTAC conjugated,LY3009120,LY3009,LY30093_003u_exp151121_run071221_31,4,003u,2021-11-15,2021-12-07,3e-6
exp151121,RAF,PROTAC conjugated,LY3009120,LY3009,LY30094_003u_exp151121_run071221_32,4,003u,2021-11-15,2021-12-07,3e-6
exp151121,RAF,PROTAC conjugated,RAF265,RAF265,RAF2651_005u_exp151121_run071221_21,4,005u,2021-11-15,2021-12-07,4.9999999999999996e-6
exp151121,RAF,PROTAC conjugated,RAF265,RAF265,RAF2652_005u_exp151121_run071221_22,4,005u,2021-11-15,2021-12-07,4.9999999999999996e-6
exp151121,RAF,PROTAC conjugated,RAF265,RAF265,RAF2653_005u_exp151121_run071221_23,4,005u,2021-11-15,2021-12-07,4.9999999999999996e-6
exp151121,RAF,PROTAC conjugated,RAF265,RAF265,RAF2654_005u_exp151121_run071221_24,4,005u,2021-11-15,2021-12-07,4.9999999999999996e-6
exp070222,RAF,PROTAC conjugated,Vemurafenib,Vemura,Vemura1_007u_exp070222_run060522_01,4,007u,2022-02-07,2022-05-06,7e-6
exp070222,RAF,PROTAC conjugated,Vemurafenib,Vemura,Vemura2_007u_exp070222_run060522_02,4,007u,2022-02-07,2022-05-06,7e-6
exp070222,RAF,PROTAC conjugated,Vemurafenib,Vemura,Vemura3_007u_exp070222_run060522_03,4,007u,2022-02-07,2022-05-06,7e-6
exp070222,RAF,PROTAC conjugated,Vemurafenib,Vemura,Vemura4_007u_exp070222_run060522_04,4,007u,2022-02-07,2022-05-06,7e-6
exp010821,MEK,PROTAC conjugated,Trametinib,Tramet,Tramet1_030n_exp010821_run180821_11,4,030n,2021-08-01,2021-08-18,3.0000000000000004e-8
exp010821,MEK,PROTAC conjugated,Trametinib,Tramet,Tramet2_030n_exp010821_run180821_12,4,030n,2021-08-01,2021-08-18,3.0000000000000004e-8
exp010821,MEK,PROTAC conjugated,Trametinib,Tramet,Tramet3_030n_exp010821_run180821_13,4,030n,2021-08-01,2021-08-18,3.0000000000000004e-8
exp010821,MEK,PROTAC conjugated,Trametinib,Tramet,Tramet4_030n_exp010821_run180821_14,4,030n,2021-08-01,2021-08-18,3.0000000000000004e-8
exp040821,MEK,PROTAC conjugated,Trametinib,Tramet,Tramet1_030n_exp040821_run180821_33,4,030n,2021-08-04,2021-08-18,3.0000000000000004e-8
exp040821,MEK,PROTAC conjugated,Trametinib,Tramet,Tramet2_030n_exp040821_run180821_34,4,030n,2021-08-04,2021-08-18,3.0000000000000004e-8
exp040821,MEK,PROTAC conjugated,Trametinib,Tramet,Tramet3_030n_exp040821_run180821_35,4,030n,2021-08-04,2021-08-18,3.0000000000000004e-8
exp040821,MEK,PROTAC conjugated,Trametinib,Tramet,Tramet4_030n_exp040821_run180821_36,4,030n,2021-08-04,2021-08-18,3.0000000000000004e-8
exp151121,MEK,PROTAC conjugated,Trametinib,Tramet,Tramet1_040n_exp151121_run071221_05,4,040n,2021-11-15,2021-12-07,4e-8
exp151121,MEK,PROTAC conjugated,Trametinib,Tramet,Tramet2_040n_exp151121_run071221_06,4,040n,2021-11-15,2021-12-07,4e-8
exp151121,MEK,PROTAC conjugated,Trametinib,Tramet,Tramet3_040n_exp151121_run071221_07,4,040n,2021-11-15,2021-12-07,4e-8
exp151121,MEK,PROTAC conjugated,Trametinib,Tramet,Tramet4_040n_exp151121_run071221_08,4,040n,2021-11-15,2021-12-07,4e-8
exp151121,MEK,PROTAC conjugated,U0126-EtOH,U0126E,U0126E1_030u_exp151121_run071221_09,4,030u,2021-11-15,2021-12-07,2.9999999999999997e-5
exp151121,MEK,PROTAC conjugated,U0126-EtOH,U0126E,U0126E2_030u_exp151121_run071221_10,4,030u,2021-11-15,2021-12-07,2.9999999999999997e-5
exp151121,MEK,PROTAC conjugated,U0126-EtOH,U0126E,U0126E3_030u_exp151121_run071221_11,4,030u,2021-11-15,2021-12-07,2.9999999999999997e-5
exp151121,MEK,PROTAC conjugated,U0126-EtOH,U0126E,U0126E4_030u_exp151121_run071221_12,4,030u,2021-11-15,2021-12-07,2.9999999999999997e-5
exp271221,ALK,ALK and c-Met,Crizotinib,Crizot,Crizot1_002u_exp271221_run140122_13,4,002u,2021-12-27,2022-01-14,2e-6
exp271221,ALK,ALK and c-Met,Crizotinib,Crizot,Crizot2_002u_exp271221_run140122_14,4,002u,2021-12-27,2022-01-14,2e-6
exp271221,ALK,ALK and c-Met,Crizotinib,Crizot,Crizot3_002u_exp271221_run140122_15,4,002u,2021-12-27,2022-01-14,2e-6
exp271221,ALK,ALK and c-Met,Crizotinib,Crizot,Crizot4_002u_exp271221_run140122_16,4,002u,2021-12-27,2022-01-14,2e-6
exp271221,ALK,ALK,TAE684 (NVP-TAE684),TAE684,TAE6841_001u_exp271221_run140122_17,4,001u,2021-12-27,2022-01-14,1e-6
exp271221,ALK,ALK,TAE684 (NVP-TAE684),TAE684,TAE6842_001u_exp271221_run140122_18,4,001u,2021-12-27,2022-01-14,1e-6
exp271221,ALK,ALK,TAE684 (NVP-TAE684),TAE684,TAE6843_001u_exp271221_run140122_19,4,001u,2021-12-27,2022-01-14,1e-6
exp271221,ALK,ALK,TAE684 (NVP-TAE684),TAE684,TAE6844_001u_exp271221_run140122_20,4,001u,2021-12-27,2022-01-14,1e-6
exp271221,FGFR,ALK,Infigratinib (BGJ398),BGJ398,BGJ3981_007u_exp271221_run140122_09,4,007u,2021-12-27,2022-01-14,7e-6
exp271221,FGFR,ALK,Infigratinib (BGJ398),BGJ398,BGJ3982_007u_exp271221_run140122_10,4,007u,2021-12-27,2022-01-14,7e-6
exp271221,FGFR,ALK,Infigratinib (BGJ398),BGJ398,BGJ3983_007u_exp271221_run140122_11,4,007u,2021-12-27,2022-01-14,7e-6
exp271221,FGFR,ALK,Infigratinib (BGJ398),BGJ398,BGJ3984_007u_exp271221_run140122_12,4,007u,2021-12-27,2022-01-14,7e-6
exp010821,Chemotherapy,antifolate,Pemetrexed,Pemetr,Pemetr1_100n_exp010821_run180821_15,4,100n,2021-08-01,2021-08-18,1.0000000000000001e-7
exp010821,Chemotherapy,antifolate,Pemetrexed,Pemetr,Pemetr2_100n_exp010821_run180821_16,4,100n,2021-08-01,2021-08-18,1.0000000000000001e-7
exp010821,Chemotherapy,antifolate,Pemetrexed,Pemetr,Pemetr3_100n_exp010821_run180821_17,4,100n,2021-08-01,2021-08-18,1.0000000000000001e-7
exp010821,Chemotherapy,antifolate,Pemetrexed,Pemetr,Pemetr4_100n_exp010821_run180821_18,4,100n,2021-08-01,2021-08-18,1.0000000000000001e-7
exp040821,Chemotherapy,antifolate,Pemetrexed,Pemetr,Pemetr1_100n_exp040821_run180821_37,4,100n,2021-08-04,2021-08-18,1.0000000000000001e-7
exp040821,Chemotherapy,antifolate,Pemetrexed,Pemetr,Pemetr2_100n_exp040821_run180821_38,4,100n,2021-08-04,2021-08-18,1.0000000000000001e-7
exp040821,Chemotherapy,antifolate,Pemetrexed,Pemetr,Pemetr3_100n_exp040821_run180821_39,4,100n,2021-08-04,2021-08-18,1.0000000000000001e-7
exp040821,Chemotherapy,antifolate,Pemetrexed,Pemetr,Pemetr4_100n_exp040821_run180821_40,4,100n,2021-08-04,2021-08-18,1.0000000000000001e-7
exp181021,Chemotherapy,antifolate,Pemetrexed,Pemetr,Pemetr1_080n_exp181021_run251121_01,4,080n,2021-10-18,2021-11-25,8e-8
exp181021,Chemotherapy,antifolate,Pemetrexed,Pemetr,Pemetr2_080n_exp181021_run251121_02,4,080n,2021-10-18,2021-11-25,8e-8
exp181021,Chemotherapy,antifolate,Pemetrexed,Pemetr,Pemetr3_080n_exp181021_run251121_03,4,080n,2021-10-18,2021-11-25,8e-8
exp181021,Chemotherapy,antifolate,Pemetrexed,Pemetr,Pemetr4_080n_exp181021_run251121_04,4,080n,2021-10-18,2021-11-25,8e-8
exp220322,Chemotherapy,antifolate,Methotrexate,Methot,Methot1_040n_exp220322_run060522_33,4,040n,2022-03-22,2022-05-06,4e-8
exp220322,Chemotherapy,antifolate,Methotrexate,Methot,Methot2_040n_exp220322_run060522_34,4,040n,2022-03-22,2022-05-06,4e-8
exp220322,Chemotherapy,antifolate,Methotrexate,Methot,Methot3_040n_exp220322_run060522_35,4,040n,2022-03-22,2022-05-06,4e-8
exp220322,Chemotherapy,antifolate,Methotrexate,Methot,Methot4_040n_exp220322_run060522_36,4,040n,2022-03-22,2022-05-06,4e-8
exp220322,Chemotherapy,antifolate,Pralatrexate,Pralat,Pralat1_003n_exp220322_run060522_29,4,003n,2022-03-22,2022-05-06,3.0000000000000004e-9
exp220322,Chemotherapy,antifolate,Pralatrexate,Pralat,Pralat2_003n_exp220322_run060522_30,4,003n,2022-03-22,2022-05-06,3.0000000000000004e-9
exp220322,Chemotherapy,antifolate,Pralatrexate,Pralat,Pralat3_003n_exp220322_run060522_31,4,003n,2022-03-22,2022-05-06,3.0000000000000004e-9
exp220322,Chemotherapy,antifolate,Pralatrexate,Pralat,Pralat4_003n_exp220322_run060522_32,4,003n,2022-03-22,2022-05-06,3.0000000000000004e-9
exp300821,Chemotherapy,platinum,Cisplatin,Cispla,Cispla1_250n_exp300821_run290921_17,4,250n,2021-08-30,2021-09-29,2.5000000000000004e-7
exp300821,Chemotherapy,platinum,Cisplatin,Cispla,Cispla2_250n_exp300821_run290921_18,4,250n,2021-08-30,2021-09-29,2.5000000000000004e-7
exp300821,Chemotherapy,platinum,Cisplatin,Cispla,Cispla3_250n_exp300821_run290921_19,4,250n,2021-08-30,2021-09-29,2.5000000000000004e-7
exp300821,Chemotherapy,platinum,Cisplatin,Cispla,Cispla4_250n_exp300821_run290921_20,4,250n,2021-08-30,2021-09-29,2.5000000000000004e-7
exp181021,Chemotherapy,platinum,Cisplatin,Cispla,Cispla1_500n_exp181021_run251121_09,4,500n,2021-10-18,2021-11-25,5.000000000000001e-7
exp181021,Chemotherapy,platinum,Cisplatin,Cispla,Cispla2_500n_exp181021_run251121_10,4,500n,2021-10-18,2021-11-25,5.000000000000001e-7
exp181021,Chemotherapy,platinum,Cisplatin,Cispla,Cispla3_500n_exp181021_run251121_11,4,500n,2021-10-18,2021-11-25,5.000000000000001e-7
exp181021,Chemotherapy,platinum,Cisplatin,Cispla,Cispla4_500n_exp181021_run251121_12,4,500n,2021-10-18,2021-11-25,5.000000000000001e-7
exp070222,Chemotherapy,platinum,Oxaliplatin,Oxalip,Oxalip1_005u_exp070222_run060522_09,4,005u,2022-02-07,2022-05-06,4.9999999999999996e-6
exp070222,Chemotherapy,platinum,Oxaliplatin,Oxalip,Oxalip2_005u_exp070222_run060522_10,4,005u,2022-02-07,2022-05-06,4.9999999999999996e-6
exp070222,Chemotherapy,platinum,Oxaliplatin,Oxalip,Oxalip3_005u_exp070222_run060522_11,4,005u,2022-02-07,2022-05-06,4.9999999999999996e-6
exp070222,Chemotherapy,platinum,Oxaliplatin,Oxalip,Oxalip4_005u_exp070222_run060522_12,4,005u,2022-02-07,2022-05-06,4.9999999999999996e-6
exp070222,Chemotherapy,platinum,Carboplatin,Carbop,Carbop1_007u_exp070222_run060522_13,4,007u,2022-02-07,2022-05-06,7e-6
exp070222,Chemotherapy,platinum,Carboplatin,Carbop,Carbop2_007u_exp070222_run060522_14,4,007u,2022-02-07,2022-05-06,7e-6
exp070222,Chemotherapy,platinum,Carboplatin,Carbop,Carbop3_007u_exp070222_run060522_15,4,007u,2022-02-07,2022-05-06,7e-6
exp070222,Chemotherapy,platinum,Carboplatin,Carbop,Carbop4_007u_exp070222_run060522_16,4,007u,2022-02-07,2022-05-06,7e-6
exp181021,Chemotherapy,topoisomerase inhibitor,Doxorubicin,Doxoru,Doxoru1_080n_exp181021_run251121_05,4,080n,2021-10-18,2021-11-25,8e-8
exp181021,Chemotherapy,topoisomerase inhibitor,Doxorubicin,Doxoru,Doxoru2_080n_exp181021_run251121_06,4,080n,2021-10-18,2021-11-25,8e-8
exp181021,Chemotherapy,topoisomerase inhibitor,Doxorubicin,Doxoru,Doxoru3_080n_exp181021_run251121_07,4,080n,2021-10-18,2021-11-25,8e-8
exp181021,Chemotherapy,topoisomerase inhibitor,Doxorubicin,Doxoru,Doxoru4_080n_exp181021_run251121_08,4,080n,2021-10-18,2021-11-25,8e-8
exp151121,Chemotherapy,alkylating agent,Mitomycin C,Mitomy,Mitomy1_002x_exp151121_run071221_37,4,0.02u,2021-11-15,2021-12-07,2e-8
exp151121,Chemotherapy,alkylating agent,Mitomycin C,Mitomy,Mitomy2_002x_exp151121_run071221_38,4,0.02u,2021-11-15,2021-12-07,2e-8
exp151121,Chemotherapy,alkylating agent,Mitomycin C,Mitomy,Mitomy3_002x_exp151121_run071221_39,4,0.02u,2021-11-15,2021-12-07,2e-8
exp151121,Chemotherapy,alkylating agent,Mitomycin C,Mitomy,Mitomy4_002x_exp151121_run071221_40,4,0.02u,2021-11-15,2021-12-07,2e-8
exp070222,Chemotherapy,Pyrimidine antagonist,5Fluorouracil,5Fluor,5Fluor1_006u_exp070222_run060522_05,4,006u,2022-02-07,2022-05-06,6e-6
exp070222,Chemotherapy,Pyrimidine antagonist,5Fluorouracil,5Fluor,5Fluor2_006u_exp070222_run060522_06,4,006u,2022-02-07,2022-05-06,6e-6
exp070222,Chemotherapy,Pyrimidine antagonist,5Fluorouracil,5Fluor,5Fluor3_006u_exp070222_run060522_07,4,006u,2022-02-07,2022-05-06,6e-6
exp070222,Chemotherapy,Pyrimidine antagonist,5Fluorouracil,5Fluor,5Fluor4_006u_exp070222_run060522_08,4,006u,2022-02-07,2022-05-06,6e-6
exp220322,Chemotherapy,Mitotic inhibitors,Paclitaxel,Paclit,Paclit1_005n_exp220322_run060522_37,4,005n,2022-03-22,2022-05-06,5e-9
exp220322,Chemotherapy,Mitotic inhibitors,Paclitaxel,Paclit,Paclit2_005n_exp220322_run060522_38,4,005n,2022-03-22,2022-05-06,5e-9
exp220322,Chemotherapy,Mitotic inhibitors,Paclitaxel,Paclit,Paclit3_005n_exp220322_run060522_39,4,005n,2022-03-22,2022-05-06,5e-9
exp220322,Chemotherapy,Mitotic inhibitors,Paclitaxel,Paclit,Paclit4_005n_exp220322_run060522_40,4,005n,2022-03-22,2022-05-06,5e-9
exp130921,Epigenetics,DNMT inhibitor,5-Azacytidine,Azacyt,"Azacyt1_1,5u_exp130921_run290921_40",4,1.50u,2021-09-13,2021-09-29,1.5e-6
exp130921,Epigenetics,DNMT inhibitor,5-Azacytidine,Azacyt,"Azacyt2_1,5u_exp130921_run290921_41",4,1.50u,2021-09-13,2021-09-29,1.5e-6
exp130921,Epigenetics,DNMT inhibitor,5-Azacytidine,Azacyt,"Azacyt3_1,5u_exp130921_run290921_42",4,1.50u,2021-09-13,2021-09-29,1.5e-6
exp130921,Epigenetics,DNMT inhibitor,5-Azacytidine,Azacyt,"Azacyt4_1,5u_exp130921_run290921_43",4,1.50u,2021-09-13,2021-09-29,1.5e-6
exp130921,Epigenetics,HDAC inhibitors,Vorinostat,Vorino,Vorino1_002u_exp130921_run290921_44,4,002u,2021-09-13,2021-09-29,2e-6
exp130921,Epigenetics,HDAC inhibitors,Vorinostat,Vorino,Vorino2_002u_exp130921_run290921_45,4,002u,2021-09-13,2021-09-29,2e-6
exp130921,Epigenetics,HDAC inhibitors,Vorinostat,Vorino,Vorino3_002u_exp130921_run290921_46,4,002u,2021-09-13,2021-09-29,2e-6
exp130921,Epigenetics,HDAC inhibitors,Vorinostat,Vorino,Vorino4_002u_exp130921_run290921_47,4,002u,2021-09-13,2021-09-29,2e-6
exp181021,Epigenetics,HDAC inhibitors,Sodium phenylbutyrate,phenyl,phenyl1_002m_exp181021_run251121_25,4,002m,2021-10-18,2021-11-25,0.002
exp181021,Epigenetics,HDAC inhibitors,Sodium phenylbutyrate,phenyl,phenyl2_002m_exp181021_run251121_26,4,002m,2021-10-18,2021-11-25,0.002
exp181021,Epigenetics,HDAC inhibitors,Sodium phenylbutyrate,phenyl,phenyl3_002m_exp181021_run251121_27,4,002m,2021-10-18,2021-11-25,0.002
exp181021,Epigenetics,HDAC inhibitors,Sodium phenylbutyrate,phenyl,phenyl4_002m_exp181021_run251121_28,4,002m,2021-10-18,2021-11-25,0.002
exp271221,Epigenetics,HDAC inhibitors,Sodium butyrate,NaButy,NaButy1_002m_exp271221_run180122_33,4,002m,2021-12-27,2022-01-18,0.002
exp271221,Epigenetics,HDAC inhibitors,Sodium butyrate,NaButy,NaButy2_002m_exp271221_run180122_34,4,002m,2021-12-27,2022-01-18,0.002
exp271221,Epigenetics,HDAC inhibitors,Sodium butyrate,NaButy,NaButy3_002m_exp271221_run180122_35,4,002m,2021-12-27,2022-01-18,0.002
exp271221,Epigenetics,HDAC inhibitors,Sodium butyrate,NaButy,NaButy4_002m_exp271221_run180122_36,4,002m,2021-12-27,2022-01-18,0.002
exp271221,Epigenetics,HDAC inhibitors,Trichostatin A,Tricho,Tricho1_110n_exp271221_run180122_37,4,110n,2021-12-27,2022-01-18,1.1e-7
exp271221,Epigenetics,HDAC inhibitors,Trichostatin A,Tricho,Tricho2_110n_exp271221_run180122_38,4,110n,2021-12-27,2022-01-18,1.1e-7
exp271221,Epigenetics,HDAC inhibitors,Trichostatin A,Tricho,Tricho3_110n_exp271221_run180122_39,4,110n,2021-12-27,2022-01-18,1.1e-7
exp271221,Epigenetics,HDAC inhibitors,Trichostatin A,Tricho,Tricho4_110n_exp271221_run180122_40,4,110n,2021-12-27,2022-01-18,1.1e-7
exp181021,Epigenetics,EZH2 inhibitor,Tazemetostat,Tazeme,Tazeme1_040u_exp181021_run251121_21,4,040u,2021-10-18,2021-11-25,3.9999999999999996e-05
exp181021,Epigenetics,EZH2 inhibitor,Tazemetostat,Tazeme,Tazeme2_040u_exp181021_run251121_22,4,040u,2021-10-18,2021-11-25,3.9999999999999996e-05
exp181021,Epigenetics,EZH2 inhibitor,Tazemetostat,Tazeme,Tazeme3_040u_exp181021_run251121_23,4,040u,2021-10-18,2021-11-25,3.9999999999999996e-05
exp181021,Epigenetics,EZH2 inhibitor,Tazemetostat,Tazeme,Tazeme4_040u_exp181021_run251121_24,4,040u,2021-10-18,2021-11-25,3.9999999999999996e-05
exp181021,Multi-kinase inhibitors,"VEGFR1-3, FGFR1-4, PDGFR, KIT, and RET",Lenvatinib,Lenvat,Lenvat1_040u_exp181021_run251121_29,4,040u,2021-10-18,2021-11-25,3.9999999999999996e-05
exp181021,Multi-kinase inhibitors,"VEGFR1-3, FGFR1-4, PDGFR, KIT, and RET",Lenvatinib,Lenvat,Lenvat2_040u_exp181021_run251121_30,4,040u,2021-10-18,2021-11-25,3.9999999999999996e-05
exp181021,Multi-kinase inhibitors,"VEGFR1-3, FGFR1-4, PDGFR, KIT, and RET",Lenvatinib,Lenvat,Lenvat3_040u_exp181021_run251121_31,4,040u,2021-10-18,2021-11-25,3.9999999999999996e-05
exp181021,Multi-kinase inhibitors,"VEGFR1-3, FGFR1-4, PDGFR, KIT, and RET",Lenvatinib,Lenvat,Lenvat4_040u_exp181021_run251121_32,4,040u,2021-10-18,2021-11-25,3.9999999999999996e-05
exp181021,Multi-kinase inhibitors,"VEGFR1/2/3, PDGFRβ, Kit, RET and RAF-1",Regorafenib,Regora,Regora1_010u_exp181021_run251121_33,4,010u,2021-10-18,2021-11-25,9.999999999999999e-6
exp181021,Multi-kinase inhibitors,"VEGFR1/2/3, PDGFRβ, Kit, RET and RAF-1",Regorafenib,Regora,Regora2_010u_exp181021_run251121_34,4,010u,2021-10-18,2021-11-25,9.999999999999999e-6
exp181021,Multi-kinase inhibitors,"VEGFR1/2/3, PDGFRβ, Kit, RET and RAF-1",Regorafenib,Regora,Regora3_010u_exp181021_run251121_35,4,010u,2021-10-18,2021-11-25,9.999999999999999e-6
exp181021,Multi-kinase inhibitors,"VEGFR1/2/3, PDGFRβ, Kit, RET and RAF-1",Regorafenib,Regora,Regora4_010u_exp181021_run251121_36,4,010u,2021-10-18,2021-11-25,9.999999999999999e-6
exp181021,Multi-kinase inhibitors,"VEGFR2, c-Met, Kit, Axl and Flt3",Cabozantinib,Caboza,Caboza1_010u_exp181021_run251121_37,4,010u,2021-10-18,2021-11-25,9.999999999999999e-6
exp181021,Multi-kinase inhibitors,"VEGFR2, c-Met, Kit, Axl and Flt3",Cabozantinib,Caboza,Caboza2_010u_exp181021_run251121_38,4,010u,2021-10-18,2021-11-25,9.999999999999999e-6
exp181021,Multi-kinase inhibitors,"VEGFR2, c-Met, Kit, Axl and Flt3",Cabozantinib,Caboza,Caboza3_010u_exp181021_run251121_39,4,010u,2021-10-18,2021-11-25,9.999999999999999e-6
exp181021,Multi-kinase inhibitors,"VEGFR2, c-Met, Kit, Axl and Flt3",Cabozantinib,Caboza,Caboza4_010u_exp181021_run251121_40,4,010u,2021-10-18,2021-11-25,9.999999999999999e-6
exp271221,Multi-kinase inhibitors,VEGFR2 and PDGFRβ,Sunitinib Malate,Suniti,Suniti1_015u_exp271221_run140122_21,4,015u,2021-12-27,2022-01-14,1.4999999999999999e-5
exp271221,Multi-kinase inhibitors,VEGFR2 and PDGFRβ,Sunitinib Malate,Suniti,Suniti2_015u_exp271221_run140122_22,4,015u,2021-12-27,2022-01-14,1.4999999999999999e-5
exp271221,Multi-kinase inhibitors,VEGFR2 and PDGFRβ,Sunitinib Malate,Suniti,Suniti3_015u_exp271221_run140122_23,4,015u,2021-12-27,2022-01-14,1.4999999999999999e-5
exp271221,Multi-kinase inhibitors,VEGFR2 and PDGFRβ,Sunitinib Malate,Suniti,Suniti4_015u_exp271221_run140122_24,4,015u,2021-12-27,2022-01-14,1.4999999999999999e-5
exp300821,Apoptosis,BCL-2 inhibitor,Navitoclax,Navito,Navito1_006u_exp300821_run290921_21,4,006u,2021-08-30,2021-09-29,6e-6
exp300821,Apoptosis,BCL-2 inhibitor,Navitoclax,Navito,Navito2_006u_exp300821_run290921_22,4,006u,2021-08-30,2021-09-29,6e-6
exp300821,Apoptosis,BCL-2 inhibitor,Navitoclax,Navito,Navito3_006u_exp300821_run290921_23,4,006u,2021-08-30,2021-09-29,6e-6
exp300821,Apoptosis,BCL-2 inhibitor,Navitoclax,Navito,Navito4_006u_exp300821_run290921_24,4,006u,2021-08-30,2021-09-29,6e-6
exp271221,Apoptosis,MCL-1 inhibitor,S63845,S63845,S638451_010u_exp271221_run140122_29,4,010u,2021-12-27,2022-01-14,9.999999999999999e-6
exp271221,Apoptosis,MCL-1 inhibitor,S63845,S63845,S638452_010u_exp271221_run140122_30,4,010u,2021-12-27,2022-01-14,9.999999999999999e-6
exp271221,Apoptosis,MCL-1 inhibitor,S63845,S63845,S638453_010u_exp271221_run140122_31,4,010u,2021-12-27,2022-01-14,9.999999999999999e-6
exp271221,Apoptosis,MCL-1 inhibitor,S63845,S63845,S638454_010u_exp271221_run140122_32,4,010u,2021-12-27,2022-01-14,9.999999999999999e-6
exp130921,JAK/STAT,Stat3 inhibitor,Napabucasin,Napabu,Napabu1_001u_exp130921_run111021_01,4,001u,2021-09-13,2021-10-11,1e-6
exp130921,JAK/STAT,Stat3 inhibitor,Napabucasin,Napabu,Napabu2_001u_exp130921_run111021_02,4,001u,2021-09-13,2021-10-11,1e-6
exp130921,JAK/STAT,Stat3 inhibitor,Napabucasin,Napabu,Napabu3_001u_exp130921_run111021_03,4,001u,2021-09-13,2021-10-11,1e-6
exp130921,JAK/STAT,Stat3 inhibitor,Napabucasin,Napabu,Napabu4_001u_exp130921_run111021_04,4,001u,2021-09-13,2021-10-11,1e-6
exp151121,JAK/STAT,Stat3 inhibitor,"Stat3 inhibitor V, stattic",statti,statti1_007u_exp151121_run180122_11,4,007u,2021-11-15,2022-01-18,7e-6
exp151121,JAK/STAT,Stat3 inhibitor,"Stat3 inhibitor V, stattic",statti,statti2_007u_exp151121_run180122_12,4,007u,2021-11-15,2022-01-18,7e-6
exp151121,JAK/STAT,Stat3 inhibitor,"Stat3 inhibitor V, stattic",statti,statti3_007u_exp151121_run180122_13,4,007u,2021-11-15,2022-01-18,7e-6
exp151121,JAK/STAT,Stat3 inhibitor,"Stat3 inhibitor V, stattic",statti,statti4_007u_exp151121_run180122_14,4,007u,2021-11-15,2022-01-18,7e-6
exp130921,JAK/STAT,JAK inhibitor,AZD1480,AZD148,AZD1481_005u_exp130921_run111021_05,4,005u,2021-09-13,2021-10-11,4.9999999999999996e-6
exp130921,JAK/STAT,JAK inhibitor,AZD1480,AZD148,AZD1482_005u_exp130921_run111021_06,4,005u,2021-09-13,2021-10-11,4.9999999999999996e-6
exp130921,JAK/STAT,JAK inhibitor,AZD1480,AZD148,AZD1483_005u_exp130921_run111021_07,4,005u,2021-09-13,2021-10-11,4.9999999999999996e-6
exp130921,JAK/STAT,JAK inhibitor,AZD1480,AZD148,AZD1484_005u_exp130921_run111021_08,4,005u,2021-09-13,2021-10-11,4.9999999999999996e-6
exp200921,Proteasomal inhibitors,JAK inhibitor,Bortezomib,Bortez,Bortez1_020n_exp200921_run111021_25,4,020n,2021-09-20,2021-10-11,2e-8
exp200921,Proteasomal inhibitors,JAK inhibitor,Bortezomib,Bortez,Bortez2_020n_exp200921_run111021_26,4,020n,2021-09-20,2021-10-11,2e-8
exp200921,Proteasomal inhibitors,JAK inhibitor,Bortezomib,Bortez,Bortez3_020n_exp200921_run111021_27,4,020n,2021-09-20,2021-10-11,2e-8
exp200921,Proteasomal inhibitors,JAK inhibitor,Bortezomib,Bortez,Bortez4_020n_exp200921_run111021_28,4,020n,2021-09-20,2021-10-11,2e-8
exp271221,Proteasomal inhibitors,JAK inhibitor,Bortezomib,Bortez,Bortez1_020n_exp271221_run180122_41,4,020n,2021-12-27,2022-01-18,2e-8
exp271221,Proteasomal inhibitors,JAK inhibitor,Bortezomib,Bortez,Bortez2_020n_exp271221_run180122_42,4,020n,2021-12-27,2022-01-18,2e-8
exp271221,Proteasomal inhibitors,JAK inhibitor,Bortezomib,Bortez,Bortez3_020n_exp271221_run180122_43,4,020n,2021-12-27,2022-01-18,2e-8
exp271221,Proteasomal inhibitors,JAK inhibitor,Bortezomib,Bortez,Bortez4_020n_exp271221_run180122_44,4,020n,2021-12-27,2022-01-18,2e-8
exp271221,Proteasomal inhibitors,JAK inhibitor,MG132,MG132z,MG132z1_510n_exp271221_run180122_45,4,510n,2021-12-27,2022-01-18,5.1e-7
exp271221,Proteasomal inhibitors,JAK inhibitor,MG132,MG132z,MG132z2_510n_exp271221_run180122_46,4,510n,2021-12-27,2022-01-18,5.1e-7
exp271221,Proteasomal inhibitors,JAK inhibitor,MG132,MG132z,MG132z3_510n_exp271221_run180122_47,4,510n,2021-12-27,2022-01-18,5.1e-7
exp271221,Proteasomal inhibitors,JAK inhibitor,MG132,MG132z,MG132z4_510n_exp271221_run180122_48,4,510n,2021-12-27,2022-01-18,5.1e-7
exp200921,Autophagy,Autophagy and toll-like receptors (TLRs) inhibitor,Chloroquine,Chloro,Chloro1_040u_exp200921_run111021_41,4,040u,2021-09-20,2021-10-11,3.9999999999999996e-05
exp200921,Autophagy,Autophagy and toll-like receptors (TLRs) inhibitor,Chloroquine,Chloro,Chloro2_040u_exp200921_run111021_42,4,040u,2021-09-20,2021-10-11,3.9999999999999996e-05
exp200921,Autophagy,Autophagy and toll-like receptors (TLRs) inhibitor,Chloroquine,Chloro,Chloro3_040u_exp200921_run111021_43,4,040u,2021-09-20,2021-10-11,3.9999999999999996e-05
exp200921,Autophagy,Autophagy and toll-like receptors (TLRs) inhibitor,Chloroquine,Chloro,Chloro4_040u_exp200921_run111021_44,4,040u,2021-09-20,2021-10-11,3.9999999999999996e-05
exp181021,Autophagy,"Ubiquitin-specific peptidases, USP10 and USP13",Spautin-1,Spauti,Spauti1_007u_exp181021_run251121_17,4,007u,2021-10-18,2021-11-25,7e-6
exp181021,Autophagy,"Ubiquitin-specific peptidases, USP10 and USP13",Spautin-1,Spauti,Spauti2_007u_exp181021_run251121_18,4,007u,2021-10-18,2021-11-25,7e-6
exp181021,Autophagy,"Ubiquitin-specific peptidases, USP10 and USP13",Spautin-1,Spauti,Spauti3_007u_exp181021_run251121_19,4,007u,2021-10-18,2021-11-25,7e-6
exp181021,Autophagy,"Ubiquitin-specific peptidases, USP10 and USP13",Spautin-1,Spauti,Spauti4_007u_exp181021_run251121_20,4,007u,2021-10-18,2021-11-25,7e-6
exp181021,Autophagy,ULK1 inhibitor,SBI-0206965,SBI020,SBI0201_005u_exp181021_run251121_13,4,005u,2021-10-18,2021-11-25,4.9999999999999996e-6
exp181021,Autophagy,ULK1 inhibitor,SBI-0206965,SBI020,SBI0202_005u_exp181021_run251121_14,4,005u,2021-10-18,2021-11-25,4.9999999999999996e-6
exp181021,Autophagy,ULK1 inhibitor,SBI-0206965,SBI020,SBI0203_005u_exp181021_run251121_15,4,005u,2021-10-18,2021-11-25,4.9999999999999996e-6
exp181021,Autophagy,ULK1 inhibitor,SBI-0206965,SBI020,SBI0204_005u_exp181021_run251121_16,4,005u,2021-10-18,2021-11-25,4.9999999999999996e-6
exp200921,Antibiotics,Inhibit vacuolar H +-ATPase,Bafilomycin-A1,Bafilo,"Bafilo1_1,2n_exp200921_run111021_45",4,1.20n,2021-09-20,2021-10-11,1.2e-9
exp200921,Antibiotics,Inhibit vacuolar H +-ATPase,Bafilomycin-A1,Bafilo,"Bafilo2_1,2n_exp200921_run111021_46",4,1.20n,2021-09-20,2021-10-11,1.2e-9
exp200921,Antibiotics,Inhibit vacuolar H +-ATPase,Bafilomycin-A1,Bafilo,"Bafilo3_1,2n_exp200921_run111021_47",4,1.20n,2021-09-20,2021-10-11,1.2e-9
exp200921,Antibiotics,Inhibit vacuolar H +-ATPase,Bafilomycin-A1,Bafilo,"Bafilo4_1,2n_exp200921_run111021_48",4,1.20n,2021-09-20,2021-10-11,1.2e-9
exp271221,Antibiotics,Dihydrofolate reductase inhibitor,Trimethoprim,Trimet,Trimet1_600u_exp271221_run140122_33,4,600u,2021-12-27,2022-01-14,6e-4
exp271221,Antibiotics,Dihydrofolate reductase inhibitor,Trimethoprim,Trimet,Trimet2_600u_exp271221_run140122_34,4,600u,2021-12-27,2022-01-14,6e-4
exp271221,Antibiotics,Dihydrofolate reductase inhibitor,Trimethoprim,Trimet,Trimet3_600u_exp271221_run140122_35,4,600u,2021-12-27,2022-01-14,6e-4
exp271221,Antibiotics,Dihydrofolate reductase inhibitor,Trimethoprim,Trimet,Trimet4_600u_exp271221_run140122_36,4,600u,2021-12-27,2022-01-14,6e-4
exp070222,Antibiotics,NLRP3 activator,Nigericin,Nigeri,Nigeri1_100n_exp070222_run060522_17,4,100n,2022-02-07,2022-05-06,1.0000000000000001e-7
exp070222,Antibiotics,NLRP3 activator,Nigericin,Nigeri,Nigeri2_100n_exp070222_run060522_18,4,100n,2022-02-07,2022-05-06,1.0000000000000001e-7
exp070222,Antibiotics,NLRP3 activator,Nigericin,Nigeri,Nigeri3_100n_exp070222_run060522_19,4,100n,2022-02-07,2022-05-06,1.0000000000000001e-7
exp070222,Antibiotics,NLRP3 activator,Nigericin,Nigeri,Nigeri4_100n_exp070222_run060522_20,4,100n,2022-02-07,2022-05-06,1.0000000000000001e-7
exp181021,MNK,MNK1 and MNK2 inhibitor,eFT-508,eFT508,eFT5081_025u_exp181021_run251121_45,4,025u,2021-10-18,2021-11-25,2.4999999999999998e-5
exp181021,MNK,MNK1 and MNK2 inhibitor,eFT-508,eFT508,eFT5082_025u_exp181021_run251121_46,4,025u,2021-10-18,2021-11-25,2.4999999999999998e-5
exp181021,MNK,MNK1 and MNK2 inhibitor,eFT-508,eFT508,eFT5083_025u_exp181021_run251121_47,4,025u,2021-10-18,2021-11-25,2.4999999999999998e-5
exp181021,MNK,MNK1 and MNK2 inhibitor,eFT-508,eFT508,eFT5084_025u_exp181021_run251121_48,4,025u,2021-10-18,2021-11-25,2.4999999999999998e-5
exp181021,MNK,MNK1 inhibitor,CGP57380,CGP573,CGP5731_010u_exp181021_run251121_41,4,010u,2021-10-18,2021-11-25,9.999999999999999e-6
exp181021,MNK,MNK1 inhibitor,CGP57380,CGP573,CGP5732_010u_exp181021_run251121_42,4,010u,2021-10-18,2021-11-25,9.999999999999999e-6
exp181021,MNK,MNK1 inhibitor,CGP57380,CGP573,CGP5733_010u_exp181021_run251121_43,4,010u,2021-10-18,2021-11-25,9.999999999999999e-6
exp181021,MNK,MNK1 inhibitor,CGP57380,CGP573,CGP5734_010u_exp181021_run251121_44,4,010u,2021-10-18,2021-11-25,9.999999999999999e-6
exp200921,AMPK,AMPK inhibitor,Dorsomorphin (Compound C) 2HCl,Compou,Compou1_008u_exp200921_run111021_17,4,008u,2021-09-20,2021-10-11,8e-6
exp200921,AMPK,AMPK inhibitor,Dorsomorphin (Compound C) 2HCl,Compou,Compou2_008u_exp200921_run111021_18,4,008u,2021-09-20,2021-10-11,8e-6
exp200921,AMPK,AMPK inhibitor,Dorsomorphin (Compound C) 2HCl,Compou,Compou3_008u_exp200921_run111021_19,4,008u,2021-09-20,2021-10-11,8e-6
exp200921,AMPK,AMPK inhibitor,Dorsomorphin (Compound C) 2HCl,Compou,Compou4_008u_exp200921_run111021_20,4,008u,2021-09-20,2021-10-11,8e-6
exp271221,AMPK,AMP phosphodiesterase (PDE) inhibitor,Ibudilast,Ibudil,Ibudil1_400u_exp271221_run140122_45,4,400u,2021-12-27,2022-01-14,3.9999999999999996e-4
exp271221,AMPK,AMP phosphodiesterase (PDE) inhibitor,Ibudilast,Ibudil,Ibudil2_400u_exp271221_run140122_46,4,400u,2021-12-27,2022-01-14,3.9999999999999996e-4
exp271221,AMPK,AMP phosphodiesterase (PDE) inhibitor,Ibudilast,Ibudil,Ibudil3_400u_exp271221_run140122_47,4,400u,2021-12-27,2022-01-14,3.9999999999999996e-4
exp271221,AMPK,AMP phosphodiesterase (PDE) inhibitor,Ibudilast,Ibudil,Ibudil4_400u_exp271221_run140122_48,4,400u,2021-12-27,2022-01-14,3.9999999999999996e-4
exp151121,AMPK,AMPK activator,Phenformin HCL,Phenfo,Phenfo1_050u_exp151121_run180122_03,4,050u,2021-11-15,2022-01-18,4.9999999999999996e-5
exp151121,AMPK,AMPK activator,Phenformin HCL,Phenfo,Phenfo2_050u_exp151121_run180122_04,4,050u,2021-11-15,2022-01-18,4.9999999999999996e-5
exp151121,AMPK,AMPK activator,Phenformin HCL,Phenfo,Phenfo3_050u_exp151121_run180122_05,4,050u,2021-11-15,2022-01-18,4.9999999999999996e-5
exp151121,AMPK,AMPK activator,Phenformin HCL,Phenfo,Phenfo4_050u_exp151121_run180122_06,4,050u,2021-11-15,2022-01-18,4.9999999999999996e-5
exp200921,ROCK,LIMK inhibitor,LIM Kinase Inhibitor I,LIMKi3,LIMKi31_030u_exp200921_run111021_21,4,030u,2021-09-20,2021-10-11,2.9999999999999997e-5
exp200921,ROCK,LIMK inhibitor,LIM Kinase Inhibitor I,LIMKi3,LIMKi32_030u_exp200921_run111021_22,4,030u,2021-09-20,2021-10-11,2.9999999999999997e-5
exp200921,ROCK,LIMK inhibitor,LIM Kinase Inhibitor I,LIMKi3,LIMKi33_030u_exp200921_run111021_23,4,030u,2021-09-20,2021-10-11,2.9999999999999997e-5
exp200921,ROCK,LIMK inhibitor,LIM Kinase Inhibitor I,LIMKi3,LIMKi34_030u_exp200921_run111021_24,4,030u,2021-09-20,2021-10-11,2.9999999999999997e-5
exp070222,ROCK,ROCK-I and ROCK-II inhibitor,Y-27632 dihydrochloride,Y27632,Y276321_300u_exp070222_run060522_21,4,300u,2022-02-07,2022-05-06,3e-4
exp070222,ROCK,ROCK-I and ROCK-II inhibitor,Y-27632 dihydrochloride,Y27632,Y276322_300u_exp070222_run060522_22,4,300u,2022-02-07,2022-05-06,3e-4
exp070222,ROCK,ROCK-I and ROCK-II inhibitor,Y-27632 dihydrochloride,Y27632,Y276323_300u_exp070222_run060522_23,4,300u,2022-02-07,2022-05-06,3e-4
exp070222,ROCK,ROCK-I and ROCK-II inhibitor,Y-27632 dihydrochloride,Y27632,Y276324_300u_exp070222_run060522_24,4,300u,2022-02-07,2022-05-06,3e-4
exp200921,CDK,CDK4/CDK6 inhibitor,Palbociclib,Palboc,Palboc1_010u_exp200921_run111021_29,4,010u,2021-09-20,2021-10-11,9.999999999999999e-6
exp200921,CDK,CDK4/CDK6 inhibitor,Palbociclib,Palboc,Palboc2_010u_exp200921_run111021_30,4,010u,2021-09-20,2021-10-11,9.999999999999999e-6
exp200921,CDK,CDK4/CDK6 inhibitor,Palbociclib,Palboc,Palboc3_010u_exp200921_run111021_31,4,010u,2021-09-20,2021-10-11,9.999999999999999e-6
exp200921,CDK,CDK4/CDK6 inhibitor,Palbociclib,Palboc,Palboc4_010u_exp200921_run111021_32,4,010u,2021-09-20,2021-10-11,9.999999999999999e-6
exp220322,CDK,CDK7 inhibitor,THZ1,THZ1,THZ11_090n_exp220322_run200522_09,4,090n,2022-03-22,2022-05-20,9.000000000000001e-8
exp220322,CDK,CDK7 inhibitor,THZ1,THZ1,THZ12_090n_exp220322_run200522_10,4,090n,2022-03-22,2022-05-20,9.000000000000001e-8
exp220322,CDK,CDK7 inhibitor,THZ1,THZ1,THZ13_090n_exp220322_run200522_11,4,090n,2022-03-22,2022-05-20,9.000000000000001e-8
exp220322,CDK,CDK7 inhibitor,THZ1,THZ1,THZ14_090n_exp220322_run200522_12,4,090n,2022-03-22,2022-05-20,9.000000000000001e-8
exp200921,PARP,PARP1/2 inhibitor,Olaparib,Olapar,Olapar1_020u_exp200921_run111021_33,4,020u,2021-09-20,2021-10-11,1.9999999999999998e-5
exp200921,PARP,PARP1/2 inhibitor,Olaparib,Olapar,Olapar2_020u_exp200921_run111021_34,4,020u,2021-09-20,2021-10-11,1.9999999999999998e-5
exp200921,PARP,PARP1/2 inhibitor,Olaparib,Olapar,Olapar3_020u_exp200921_run111021_35,4,020u,2021-09-20,2021-10-11,1.9999999999999998e-5
exp200921,PARP,PARP1/2 inhibitor,Olaparib,Olapar,Olapar4_020u_exp200921_run111021_36,4,020u,2021-09-20,2021-10-11,1.9999999999999998e-5
exp220322,Wnt,Tankyrase inhibitor,XAV-939,XAV939,XAV9391_080u_exp220322_run060522_45,4,080u,2022-03-22,2022-05-06,7.999999999999999e-5
exp220322,Wnt,Tankyrase inhibitor,XAV-939,XAV939,XAV9392_080u_exp220322_run060522_46,4,080u,2022-03-22,2022-05-06,7.999999999999999e-5
exp200921,Wnt,Porcupine inhibitor,LGK974,LGK974,LGK9741_005u_exp200921_run111021_37,4,005u,2021-09-20,2021-10-11,4.9999999999999996e-6
exp200921,Wnt,Porcupine inhibitor,LGK974,LGK974,LGK9742_005u_exp200921_run111021_38,4,005u,2021-09-20,2021-10-11,4.9999999999999996e-6
exp200921,Wnt,Porcupine inhibitor,LGK974,LGK974,LGK9743_005u_exp200921_run111021_39,4,005u,2021-09-20,2021-10-11,4.9999999999999996e-6
exp200921,Wnt,Porcupine inhibitor,LGK974,LGK974,LGK9744_005u_exp200921_run111021_40,4,005u,2021-09-20,2021-10-11,4.9999999999999996e-6
exp151121,CaM-KK,CaM-KK inhibitor,STO-609,STO609,STO6091_030u_exp151121_run071221_41,4,030u,2021-11-15,2021-12-07,2.9999999999999997e-5
exp151121,CaM-KK,CaM-KK inhibitor,STO-609,STO609,STO6092_030u_exp151121_run071221_42,4,030u,2021-11-15,2021-12-07,2.9999999999999997e-5
exp151121,CaM-KK,CaM-KK inhibitor,STO-609,STO609,STO6093_030u_exp151121_run071221_43,4,030u,2021-11-15,2021-12-07,2.9999999999999997e-5
exp151121,CaM-KK,CaM-KK inhibitor,STO-609,STO609,STO6094_030u_exp151121_run071221_44,4,030u,2021-11-15,2021-12-07,2.9999999999999997e-5
exp151121,AKT,AKT inhibitor,Capivasertib (AZD5363),Capiva,Capiva1_050u_exp151121_run071221_45,4,050u,2021-11-15,2021-12-07,4.9999999999999996e-5
exp151121,AKT,AKT inhibitor,Capivasertib (AZD5363),Capiva,Capiva2_050u_exp151121_run071221_46,4,050u,2021-11-15,2021-12-07,4.9999999999999996e-5
exp151121,AKT,AKT inhibitor,Capivasertib (AZD5363),Capiva,Capiva3_050u_exp151121_run071221_47,4,050u,2021-11-15,2021-12-07,4.9999999999999996e-5
exp151121,AKT,AKT inhibitor,Capivasertib (AZD5363),Capiva,Capiva4_050u_exp151121_run071221_48,4,050u,2021-11-15,2021-12-07,4.9999999999999996e-5
exp271221,ERK1/RasGAP,ERK1 and RasGAP inhibitor,Pluripotin (SC-1),Plurip,Plurip1_010u_exp271221_run140122_25,4,010u,2021-12-27,2022-01-14,9.999999999999999e-6
exp271221,ERK1/RasGAP,ERK1 and RasGAP inhibitor,Pluripotin (SC-1),Plurip,Plurip2_010u_exp271221_run140122_26,4,010u,2021-12-27,2022-01-14,9.999999999999999e-6
exp271221,ERK1/RasGAP,ERK1 and RasGAP inhibitor,Pluripotin (SC-1),Plurip,Plurip3_010u_exp271221_run140122_27,4,010u,2021-12-27,2022-01-14,9.999999999999999e-6
exp271221,ERK1/RasGAP,ERK1 and RasGAP inhibitor,Pluripotin (SC-1),Plurip,Plurip4_010u_exp271221_run140122_28,4,010u,2021-12-27,2022-01-14,9.999999999999999e-6
exp271221,Antioxidant,ROS inhibitor,N-Acetyl-L-cysteine (NAC),NAcety,NAcety1_015m_exp271221_run140122_37,4,015m,2021-12-27,2022-01-14,0.015
exp271221,Antioxidant,ROS inhibitor,N-Acetyl-L-cysteine (NAC),NAcety,NAcety2_015m_exp271221_run140122_38,4,015m,2021-12-27,2022-01-14,0.015
exp271221,Antioxidant,ROS inhibitor,N-Acetyl-L-cysteine (NAC),NAcety,NAcety3_015m_exp271221_run140122_39,4,015m,2021-12-27,2022-01-14,0.015
exp271221,Antioxidant,ROS inhibitor,N-Acetyl-L-cysteine (NAC),NAcety,NAcety4_015m_exp271221_run140122_40,4,015m,2021-12-27,2022-01-14,0.015
exp271221,p53,Inhibition of MDM2-mediated degradation of p53,Nutlin3,Nutlin,Nutlin1_025u_exp271221_run140122_41,4,025u,2021-12-27,2022-01-14,2.4999999999999998e-5
exp271221,p53,Inhibition of MDM2-mediated degradation of p53,Nutlin3,Nutlin,Nutlin2_025u_exp271221_run140122_42,4,025u,2021-12-27,2022-01-14,2.4999999999999998e-5
exp271221,p53,Inhibition of MDM2-mediated degradation of p53,Nutlin3,Nutlin,Nutlin3_025u_exp271221_run140122_43,4,025u,2021-12-27,2022-01-14,2.4999999999999998e-5
exp271221,p53,Inhibition of MDM2-mediated degradation of p53,Nutlin3,Nutlin,Nutlin4_025u_exp271221_run140122_44,4,025u,2021-12-27,2022-01-14,2.4999999999999998e-5
exp151121,SHP2,SHP2 inhibitor,SHP099 HCL,SHP099,SHP0991_050u_exp151121_run180122_07,4,050u,2021-11-15,2022-01-18,4.9999999999999996e-5
exp151121,SHP2,SHP2 inhibitor,SHP099 HCL,SHP099,SHP0992_050u_exp151121_run180122_08,4,050u,2021-11-15,2022-01-18,4.9999999999999996e-5
exp151121,SHP2,SHP2 inhibitor,SHP099 HCL,SHP099,SHP0993_050u_exp151121_run180122_09,4,050u,2021-11-15,2022-01-18,4.9999999999999996e-5
exp151121,SHP2,SHP2 inhibitor,SHP099 HCL,SHP099,SHP0994_050u_exp151121_run180122_10,4,050u,2021-11-15,2022-01-18,4.9999999999999996e-5
exp300821,Drug combinations,EGFR-TKI + multikinase inhibitor,Osimertinb+sorafenib,OsiSor,OsiSor1_015u_exp300821_run290921_09,4,015u,2021-08-30,2021-09-29,1.4999999999999999e-5
exp300821,Drug combinations,EGFR-TKI + multikinase inhibitor,Osimertinb+sorafenib,OsiSor,OsiSor2_015u_exp300821_run290921_10,4,015u,2021-08-30,2021-09-29,1.4999999999999999e-5
exp300821,Drug combinations,EGFR-TKI + multikinase inhibitor,Osimertinb+sorafenib,OsiSor,OsiSor3_015u_exp300821_run290921_11,4,015u,2021-08-30,2021-09-29,1.4999999999999999e-5
exp300821,Drug combinations,EGFR-TKI + multikinase inhibitor,Osimertinb+sorafenib,OsiSor,OsiSor4_015u_exp300821_run290921_12,4,015u,2021-08-30,2021-09-29,1.4999999999999999e-5
exp200921,New compounds from KIT,EGFR-TKI + multikinase inhibitor,X13271,X13271,X132711_008u_exp200921_run111021_13,4,008u,2021-09-20,2021-10-11,8e-6
exp200921,New compounds from KIT,EGFR-TKI + multikinase inhibitor,X13271,X13271,X132712_008u_exp200921_run111021_14,4,008u,2021-09-20,2021-10-11,8e-6
exp200921,New compounds from KIT,EGFR-TKI + multikinase inhibitor,X13271,X13271,X132713_008u_exp200921_run111021_15,4,008u,2021-09-20,2021-10-11,8e-6
exp200921,New compounds from KIT,EGFR-TKI + multikinase inhibitor,X13271,X13271,X132714_008u_exp200921_run111021_16,4,008u,2021-09-20,2021-10-11,8e-6
exp181021,New compounds from KIT,EGFR-TKI + multikinase inhibitor,X13271,X13271,X132711_008u_exp181021_run101121_42,4,008u,2021-10-18,2021-11-10,8e-6
exp181021,New compounds from KIT,EGFR-TKI + multikinase inhibitor,X13271,X13271,X132712_008u_exp181021_run101121_43,4,008u,2021-10-18,2021-11-10,8e-6
exp181021,New compounds from KIT,EGFR-TKI + multikinase inhibitor,X13271,X13271,X132713_008u_exp181021_run101121_44,4,008u,2021-10-18,2021-11-10,8e-6
exp181021,New compounds from KIT,EGFR-TKI + multikinase inhibitor,X13271,X13271,X132714_008u_exp181021_run101121_45,4,008u,2021-10-18,2021-11-10,8e-6
exp271221,New compounds from KIT,EGFR-TKI + multikinase inhibitor,X13271,X13271,X132711_009u_exp271221_run180122_21,4,009u,2021-12-27,2022-01-18,9e-6
exp271221,New compounds from KIT,EGFR-TKI + multikinase inhibitor,X13271,X13271,X132712_009u_exp271221_run180122_22,4,009u,2021-12-27,2022-01-18,9e-6
exp271221,New compounds from KIT,EGFR-TKI + multikinase inhibitor,X13271,X13271,X132713_009u_exp271221_run180122_23,4,009u,2021-12-27,2022-01-18,9e-6
exp271221,New compounds from KIT,EGFR-TKI + multikinase inhibitor,X13271,X13271,X132714_009u_exp271221_run180122_24,4,009u,2021-12-27,2022-01-18,9e-6
exp181021,New compounds from KIT,EGFR-TKI + multikinase inhibitor,X17129,X17129,X171291_008u_exp181021_run101121_46,3,008u,2021-10-18,2021-11-10,8e-6
exp181021,New compounds from KIT,EGFR-TKI + multikinase inhibitor,X17129,X17129,X171292_008u_exp181021_run101121_47,3,008u,2021-10-18,2021-11-10,8e-6
exp181021,New compounds from KIT,EGFR-TKI + multikinase inhibitor,X17129,X17129,X171293_008u_exp181021_run101121_48,3,008u,2021-10-18,2021-11-10,8e-6
exp271221,New compounds from KIT,EGFR-TKI + multikinase inhibitor,X17129,X17129,X171291_008u_exp271221_run180122_25,4,008u,2021-12-27,2022-01-18,8e-6
exp271221,New compounds from KIT,EGFR-TKI + multikinase inhibitor,X17129,X17129,X171292_008u_exp271221_run180122_26,4,008u,2021-12-27,2022-01-18,8e-6
exp271221,New compounds from KIT,EGFR-TKI + multikinase inhibitor,X17129,X17129,X171293_008u_exp271221_run180122_27,4,008u,2021-12-27,2022-01-18,8e-6
exp271221,New compounds from KIT,EGFR-TKI + multikinase inhibitor,X17129,X17129,X171294_008u_exp271221_run180122_28,4,008u,2021-12-27,2022-01-18,8e-6
exp271221,New compounds from KIT,EGFR-TKI + multikinase inhibitor,X15681,X15681,X156811_050u_exp271221_run180122_29,4,050u,2021-12-27,2022-01-18,4.9999999999999996e-5
exp271221,New compounds from KIT,EGFR-TKI + multikinase inhibitor,X15681,X15681,X156812_050u_exp271221_run180122_30,4,050u,2021-12-27,2022-01-18,4.9999999999999996e-5
exp271221,New compounds from KIT,EGFR-TKI + multikinase inhibitor,X15681,X15681,X156813_050u_exp271221_run180122_31,4,050u,2021-12-27,2022-01-18,4.9999999999999996e-5
exp271221,New compounds from KIT,EGFR-TKI + multikinase inhibitor,X15681,X15681,X156814_050u_exp271221_run180122_32,4,050u,2021-12-27,2022-01-18,4.9999999999999996e-5
exp070222,ER stress,EGFR-TKI + multikinase inhibitor,Tunicamycin,Tunica,"Tunica1_0,5x_exp070222_run010322_05",4,0.50u,2022-02-07,2022-03-01,5e-7
exp070222,ER stress,EGFR-TKI + multikinase inhibitor,Tunicamycin,Tunica,"Tunica2_0,5x_exp070222_run010322_06",4,0.50u,2022-02-07,2022-03-01,5e-7
exp070222,ER stress,EGFR-TKI + multikinase inhibitor,Tunicamycin,Tunica,"Tunica3_0,5x_exp070222_run010322_07",4,0.50u,2022-02-07,2022-03-01,5e-7
exp070222,ER stress,EGFR-TKI + multikinase inhibitor,Tunicamycin,Tunica,"Tunica4_0,5x_exp070222_run010322_08",4,0.50u,2022-02-07,2022-03-01,5e-7
exp070222,ER stress,EGFR-TKI + multikinase inhibitor,Thapsigargin,Thapsi,Thapsi1_008n_exp070222_run010322_09,4,008n,2022-02-07,2022-03-01,8e-9
exp070222,ER stress,EGFR-TKI + multikinase inhibitor,Thapsigargin,Thapsi,Thapsi2_008n_exp070222_run010322_10,4,008n,2022-02-07,2022-03-01,8e-9
exp070222,ER stress,EGFR-TKI + multikinase inhibitor,Thapsigargin,Thapsi,Thapsi3_008n_exp070222_run010322_11,4,008n,2022-02-07,2022-03-01,8e-9
exp070222,ER stress,EGFR-TKI + multikinase inhibitor,Thapsigargin,Thapsi,Thapsi4_008n_exp070222_run010322_12,4,008n,2022-02-07,2022-03-01,8e-9
exp220322,ER stress,EGFR-TKI + multikinase inhibitor,CCT020312,CCT020,CCT0201_003u_exp220322_run200522_29,4,003u,2022-03-22,2022-05-20,3e-6
exp220322,ER stress,EGFR-TKI + multikinase inhibitor,CCT020312,CCT020,CCT0202_003u_exp220322_run200522_30,4,003u,2022-03-22,2022-05-20,3e-6
exp220322,ER stress,EGFR-TKI + multikinase inhibitor,CCT020312,CCT020,CCT0203_003u_exp220322_run200522_31,4,003u,2022-03-22,2022-05-20,3e-6
exp220322,ER stress,EGFR-TKI + multikinase inhibitor,CCT020312,CCT020,CCT0204_003u_exp220322_run200522_32,4,003u,2022-03-22,2022-05-20,3e-6
exp070222,Ferroptosis,EGFR-TKI + multikinase inhibitor,Erastin,Erasti,Erasti1_015u_exp070222_run010322_13,4,015u,2022-02-07,2022-03-01,1.4999999999999999e-5
exp070222,Ferroptosis,EGFR-TKI + multikinase inhibitor,Erastin,Erasti,Erasti2_015u_exp070222_run010322_14,4,015u,2022-02-07,2022-03-01,1.4999999999999999e-5
exp070222,Ferroptosis,EGFR-TKI + multikinase inhibitor,Erastin,Erasti,Erasti3_015u_exp070222_run010322_15,4,015u,2022-02-07,2022-03-01,1.4999999999999999e-5
exp070222,Ferroptosis,EGFR-TKI + multikinase inhibitor,Erastin,Erasti,Erasti4_015u_exp070222_run010322_16,4,015u,2022-02-07,2022-03-01,1.4999999999999999e-5
exp070222,Ferroptosis,EGFR-TKI + multikinase inhibitor,Ferrostatin1,Ferros,Ferros1_060u_exp070222_run010322_17,4,060u,2022-02-07,2022-03-01,5.9999999999999995e-5
exp070222,Ferroptosis,EGFR-TKI + multikinase inhibitor,Ferrostatin1,Ferros,Ferros2_060u_exp070222_run010322_18,4,060u,2022-02-07,2022-03-01,5.9999999999999995e-5
exp070222,Ferroptosis,EGFR-TKI + multikinase inhibitor,Ferrostatin1,Ferros,Ferros3_060u_exp070222_run010322_19,4,060u,2022-02-07,2022-03-01,5.9999999999999995e-5
exp070222,Ferroptosis,EGFR-TKI + multikinase inhibitor,Ferrostatin1,Ferros,Ferros4_060u_exp070222_run010322_20,4,060u,2022-02-07,2022-03-01,5.9999999999999995e-5
exp070222,Ferroptosis,EGFR-TKI + multikinase inhibitor,Deferoxamine mesylate,Defero,Defero1_007u_exp070222_run010322_21,4,007u,2022-02-07,2022-03-01,7e-6
exp070222,Ferroptosis,EGFR-TKI + multikinase inhibitor,Deferoxamine mesylate,Defero,Defero2_007u_exp070222_run010322_22,4,007u,2022-02-07,2022-03-01,7e-6
exp070222,Ferroptosis,EGFR-TKI + multikinase inhibitor,Deferoxamine mesylate,Defero,Defero3_007u_exp070222_run010322_23,4,007u,2022-02-07,2022-03-01,7e-6
exp070222,Ferroptosis,EGFR-TKI + multikinase inhibitor,Deferoxamine mesylate,Defero,Defero4_007u_exp070222_run010322_24,4,007u,2022-02-07,2022-03-01,7e-6
exp070222,GPX4,EGFR-TKI + multikinase inhibitor,ML-210,ML210-,ML210-1_030u_exp070222_run010322_25,4,030u,2022-02-07,2022-03-01,2.9999999999999997e-5
exp070222,GPX4,EGFR-TKI + multikinase inhibitor,ML-210,ML210-,ML210-2_030u_exp070222_run010322_26,4,030u,2022-02-07,2022-03-01,2.9999999999999997e-5
exp070222,GPX4,EGFR-TKI + multikinase inhibitor,ML-210,ML210-,ML210-3_030u_exp070222_run010322_27,4,030u,2022-02-07,2022-03-01,2.9999999999999997e-5
exp070222,GPX4,EGFR-TKI + multikinase inhibitor,ML-210,ML210-,ML210-4_030u_exp070222_run010322_28,4,030u,2022-02-07,2022-03-01,2.9999999999999997e-5
exp070222,Notch,EGFR-TKI + multikinase inhibitor,IMR-1,IMR1-,IMR1-1_080u_exp070222_run010322_29,4,080u,2022-02-07,2022-03-01,7.999999999999999e-5
exp070222,Notch,EGFR-TKI + multikinase inhibitor,IMR-1,IMR1-,IMR1-2_080u_exp070222_run010322_30,4,080u,2022-02-07,2022-03-01,7.999999999999999e-5
exp070222,Notch,EGFR-TKI + multikinase inhibitor,IMR-1,IMR1-,IMR1-3_080u_exp070222_run010322_31,4,080u,2022-02-07,2022-03-01,7.999999999999999e-5
exp070222,Notch,EGFR-TKI + multikinase inhibitor,IMR-1,IMR1-,IMR1-4_080u_exp070222_run010322_32,4,080u,2022-02-07,2022-03-01,7.999999999999999e-5
exp220322,β3-adrenergic receptor partial agonist,EGFR-TKI + multikinase inhibitor,"L-755,507",L75550,L755501_025u_exp220322_run060522_41,4,025u,2022-03-22,2022-05-06,2.4999999999999998e-5
exp220322,β3-adrenergic receptor partial agonist,EGFR-TKI + multikinase inhibitor,"L-755,507",L75550,L755502_025u_exp220322_run060522_42,4,025u,2022-03-22,2022-05-06,2.4999999999999998e-5
exp220322,β3-adrenergic receptor partial agonist,EGFR-TKI + multikinase inhibitor,"L-755,507",L75550,L755503_025u_exp220322_run060522_43,4,025u,2022-03-22,2022-05-06,2.4999999999999998e-5
exp220322,β3-adrenergic receptor partial agonist,EGFR-TKI + multikinase inhibitor,"L-755,507",L75550,L755504_025u_exp220322_run060522_44,4,025u,2022-03-22,2022-05-06,2.4999999999999998e-5
exp220322,Gap junction,Pannexin 1 inhibitor,Probenecid,Proben,Proben1_500u_exp220322_run200522_37,4,500u,2022-03-22,2022-05-20,5e-4
exp220322,Gap junction,Pannexin 1 inhibitor,Probenecid,Proben,Proben2_500u_exp220322_run200522_38,4,500u,2022-03-22,2022-05-20,5e-4
exp220322,Gap junction,Pannexin 1 inhibitor,Probenecid,Proben,Proben3_500u_exp220322_run200522_39,4,500u,2022-03-22,2022-05-20,5e-4
exp220322,Gap junction,Pannexin 1 inhibitor,Probenecid,Proben,Proben4_500u_exp220322_run200522_40,4,500u,2022-03-22,2022-05-20,5e-4
exp220322,Gap junction,Connexin inhibitor,Mefloquine hydrochloride,Mefloq,Mefloq1_010u_exp220322_run200522_41,4,010u,2022-03-22,2022-05-20,9.999999999999999e-6
exp220322,Gap junction,Connexin inhibitor,Mefloquine hydrochloride,Mefloq,Mefloq2_010u_exp220322_run200522_42,4,010u,2022-03-22,2022-05-20,9.999999999999999e-6
exp220322,Gap junction,Connexin inhibitor,Mefloquine hydrochloride,Mefloq,Mefloq3_010u_exp220322_run200522_43,4,010u,2022-03-22,2022-05-20,9.999999999999999e-6
exp220322,Gap junction,Connexin inhibitor,Mefloquine hydrochloride,Mefloq,Mefloq4_010u_exp220322_run200522_44,4,010u,2022-03-22,2022-05-20,9.999999999999999e-6
exp220322,Src inhibitor,Connexin inhibitor,Saracatinib,Saraca,Saraca1_500n_exp220322_run200522_05,4,500n,2022-03-22,2022-05-20,5.000000000000001e-7
exp220322,Src inhibitor,Connexin inhibitor,Saracatinib,Saraca,Saraca2_500n_exp220322_run200522_06,4,500n,2022-03-22,2022-05-20,5.000000000000001e-7
exp220322,Src inhibitor,Connexin inhibitor,Saracatinib,Saraca,Saraca3_500n_exp220322_run200522_07,4,500n,2022-03-22,2022-05-20,5.000000000000001e-7
exp220322,Src inhibitor,Connexin inhibitor,Saracatinib,Saraca,Saraca4_500n_exp220322_run200522_08,4,500n,2022-03-22,2022-05-20,5.000000000000001e-7
exp220322,IGF-1R,Connexin inhibitor,BMS-536924,BMS536,BMS5361_002u_exp220322_run200522_13,4,002u,2022-03-22,2022-05-20,2e-6
exp220322,IGF-1R,Connexin inhibitor,BMS-536924,BMS536,BMS5362_002u_exp220322_run200522_14,4,002u,2022-03-22,2022-05-20,2e-6
exp220322,IGF-1R,Connexin inhibitor,BMS-536924,BMS536,BMS5363_002u_exp220322_run200522_15,4,002u,2022-03-22,2022-05-20,2e-6
exp220322,IGF-1R,Connexin inhibitor,BMS-536924,BMS536,BMS5364_002u_exp220322_run200522_16,4,002u,2022-03-22,2022-05-20,2e-6
exp220322,NF-κB,Connexin inhibitor,JSH-23,JSH23,JSH231_060u_exp220322_run200522_17,4,060u,2022-03-22,2022-05-20,5.9999999999999995e-5
exp220322,NF-κB,Connexin inhibitor,JSH-23,JSH23,JSH232_060u_exp220322_run200522_18,4,060u,2022-03-22,2022-05-20,5.9999999999999995e-5
exp220322,NF-κB,Connexin inhibitor,JSH-23,JSH23,JSH233_060u_exp220322_run200522_19,4,060u,2022-03-22,2022-05-20,5.9999999999999995e-5
exp220322,NF-κB,Connexin inhibitor,JSH-23,JSH23,JSH234_060u_exp220322_run200522_20,4,060u,2022-03-22,2022-05-20,5.9999999999999995e-5
exp220322,mTOR,Connexin inhibitor,Temsirolimus,Temsir,Temsir1_006u_exp220322_run200522_25,4,006u,2022-03-22,2022-05-20,6e-6
exp220322,mTOR,Connexin inhibitor,Temsirolimus,Temsir,Temsir2_006u_exp220322_run200522_26,4,006u,2022-03-22,2022-05-20,6e-6
exp220322,mTOR,Connexin inhibitor,Temsirolimus,Temsir,Temsir3_006u_exp220322_run200522_27,4,006u,2022-03-22,2022-05-20,6e-6
exp220322,mTOR,Connexin inhibitor,Temsirolimus,Temsir,Temsir4_006u_exp220322_run200522_28,4,006u,2022-03-22,2022-05-20,6e-6
exp220322,PI3K,Connexin inhibitor,AZD8186,AZD818,AZD8181_050u_exp220322_run200522_21,4,050u,2022-03-22,2022-05-20,4.9999999999999996e-5
exp220322,PI3K,Connexin inhibitor,AZD8186,AZD818,AZD8182_050u_exp220322_run200522_22,4,050u,2022-03-22,2022-05-20,4.9999999999999996e-5
exp220322,PI3K,Connexin inhibitor,AZD8186,AZD818,AZD8183_050u_exp220322_run200522_23,4,050u,2022-03-22,2022-05-20,4.9999999999999996e-5
exp220322,PI3K,Connexin inhibitor,AZD8186,AZD818,AZD8184_050u_exp220322_run200522_24,4,050u,2022-03-22,2022-05-20,4.9999999999999996e-5
exp220322,Mitochondrial biogenesis,Connexin inhibitor,Levofloxacin,Levofl,Levofl1_250u_exp220322_run200522_33,4,250u,2022-03-22,2022-05-20,2.5e-4
exp220322,Mitochondrial biogenesis,Connexin inhibitor,Levofloxacin,Levofl,Levofl2_250u_exp220322_run200522_34,4,250u,2022-03-22,2022-05-20,2.5e-4
exp220322,Mitochondrial biogenesis,Connexin inhibitor,Levofloxacin,Levofl,Levofl3_250u_exp220322_run200522_35,4,250u,2022-03-22,2022-05-20,2.5e-4
exp220322,Mitochondrial biogenesis,Connexin inhibitor,Levofloxacin,Levofl,Levofl4_250u_exp220322_run200522_36,4,250u,2022-03-22,2022-05-20,2.5e-4
